1-4 of 4
Ana García-Noblejas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine for Mantle Cell Lymphoma: Retrospective Analysis of the Spanish Experience

Ana García-Noblejas, MD, Belén Navarro Matilla, MD, Carolina Da Silva Rodriguez, Raquel De Oña Navarrete, MD, María José Ramirez Sánchez, MD, Concepción Nicolás, MD, Ricardo Pérez Fernández, Blanca Sanchez Gonzalez, MD, Eva Domingo-Domènech, MD, Jose Javier Sanchez Blanco, MD, Jimena Cannata-Ortiz, MD, Tomás José González-López, MD, Reyes Arranz Sáez, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4942.
https://doi.org/10.1182/blood.V118.21.4942.4942
Published: 2011
Journal Articles

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Guillermo Orti, MD, Jaime Sanz, MD, Arancha Bermudez, Dolores Caballero, MD, Carmen Martinez, MD, Jordi Sierra, MD, PhD, José R. Cabrera Marin, Ildefonso Espigado, MD, PhD, Carlos Solano, Christelle Ferrà, Ana García-Noblejas, MD, Santiago Jimenez, Antonia Sampol, MD, Monica Lopez Duarte, Valentin Garcia, Maria Jesus Pascual, Manuel Jurado, José M. Moraleda, Miguel A. Sanz, MD, PhD, Enric Carreras, MD, PhD, Rafael F. Duarte, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3056.
https://doi.org/10.1182/blood.V118.21.3056.3056
Published: 2011
Journal Articles

Myeloablative Conditioning with Intravenous Busulfan In One Daily Dose and Fludarabine (BUF) for HLA-Identical Sibling Allogeneic HSCT In Myeloid Malignancies

Javier De la Serna, MD, PhD, Jaime Sanz, MD, Arancha Bermudez, Carlos Vallejo, MD, PhD, David Serrano, Dolores Caballero, MD, Rafael De La Camara, MD, José M. Moraleda, Sonia Gonzalez, Ana García-Noblejas, MD, M. Cabrero, Juan José Lahuerta, Arturo Iriondo, Luis Benlloch, Guillermo Sanz, MD
Journal: Blood
Blood (2011) 118 (21): 3010.
https://doi.org/10.1182/blood.V118.21.3010.3010
Published: 2011
Journal Articles

The Addition of Rituximab to CVP (Bagley) + Interferon-α as Induction Regimen, Significantly Increases Complete Remission Rates and Progression Free Survival In Intermediate-High Risk Follicular Lymphoma Patients (LNH-pro vs . LNH-pro-05 trial)

Jimena Cannata-Ortiz, Concepción Nicolás, Ana García-Noblejas, Javier Lopez, Maria José Requena, Concepción Alaez, Adrian Alegre, Reyes Arranz
Journal: Blood
Blood (2010) 116 (21): 2867.
https://doi.org/10.1182/blood.V116.21.2867.2867
Published: 2010